Despite a challenging consumer environment, the CEO remains confident due to the strength of the private brands market. However, the company's shares fell 6.36% in premarket trading post-earnings report.
TreeHouse Foods' steady decrease in revenue and share price over the past five years warns potential investors about possible future underperformance. Contrarian investors, however, might see a turnaround opportunity.
The company's CEO expressed optimism about capitalizing on the increasing consumer shift to private brands and believes actions taken to strengthen their portfolio and enhance capabilities, along with reinvestment opportunities, will ensure long-term value creation for shareholders.
The acquisition is expected to deepen TreeHouse Foods' position in the pickle category and facilitate expansion into Canada, potentially positioning the company for continued success.
RDK79
:
Only noted more downgraded than upgrades, lot of analysts late to the party. And a bunch of new ‘initiated’ by mostly unknown folks, but also a few surprised weren’t previously covered, like DIS.
Treehouse Foods Stock Forum
$S&P 500 Index (.SPX.US)$ $E-mini NASDAQ 100 Futures(MAR5) (NQmain.US)$ $Walmart (WMT.US)$ $Starbucks (SBUX.US)$ $Amazon (AMZN.US)$ $Costco (COST.US)$ $Eli Lilly and Co (LLY.US)$ $McDonald's (MCD.US)$ $Treehouse Foods (THS.US)$ $Darden Restaurants (DRI.US)$ $CarMax (KMX.US)$ $The Wendy's Co (WEN.US)$
$Apyx Medical (APYX.US)$ $Addentax (ATXG.US)$ $Axsome Therapeutics (AXSM.US)$ $BioXcel Therapeutics (BTAI.US)$ $Baudax Bio (BXRX.US)$ $CymaBay Therapeutics (CBAY.US)$ $CorMedix (CRMD.US)$ $Marriott International (MAR.US)$ $Microvision (MVIS.US)$ $Renalytix (RNLX.US)$ $State Street (STT.US)$ $Treehouse Foods (THS.US)$ $Targa Resources (TRGP.US)$ $VBI Vaccines (VBIV.US)$ $Ventas Inc (VTR.US)$
In reaction to earnings/guidance:
• $Karuna Therapeutics (KRTX.US)$ +42.6% (also reports topline results from its Phase3 EMERGENT-2 trial evaluating the efficacy, safety, and tolerability of its lead investigational therapy, KarXT), $monday.com (MNDY.US)$ +15.1%, $W&T Offshore (WTI.US)$ +6.7%, $HF Sinclair (DINO.US)$ +5.3%, $Viatris (VTRS.US)$ +4.3%, $Kosmos Energy (KOS.US)$ + 3.2%, $Holly Energy (HEP.US)$ +3.2%, $Barrick Gold (GOLD.US)$ +2.9%, ...
• $Genco Shipping & Trading (GNK.US)$ +4.7% (positive Barrons article)
• $NextDecade (NEXT.US)$ +4.7% (files for 4618226 share common stock offering by selling shareholder)
• $COMPASS Pathways (CMPS.US)$ +4.7% (COMPASS Pathways presents largest ever study of psilocybin therapy at American Psychiatric Association annual meeting)
• $Canoo (GOEV.US)$ +3.5% (files for 48043111 share common stock offering by selling shareholder)
• $American Axle & Mfg (AXL.US)$ +3.7% (pr...
• $CubeSmart (CUBE.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $52 (from $60)
• $DTE Energy (DTE.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $140 (from $142)
• $Consolidated Edison (ED.US)$ : Guggenheim Upgrades to Neutral from Sell - PT $94 (from $80)
• $Motorola Solutions (MSI.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $240
• $Central North Airport (OMAB.US)$ : Morgan Stanley Upgrades to...
No comment yet